0000088053-17-001179.txt : 20170726 0000088053-17-001179.hdr.sgml : 20170726 20170726152313 ACCESSION NUMBER: 0000088053-17-001179 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170531 FILED AS OF DATE: 20170726 DATE AS OF CHANGE: 20170726 EFFECTIVENESS DATE: 20170726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEUTSCHE INTERNATIONAL FUND, INC. CENTRAL INDEX KEY: 0000088053 IRS NUMBER: 132827803 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-00642 FILM NUMBER: 17982666 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10154-0004 BUSINESS PHONE: 212-454-6778 MAIL ADDRESS: STREET 1: 345 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10154-0004 FORMER COMPANY: FORMER CONFORMED NAME: DWS INTERNATIONAL FUND, INC. DATE OF NAME CHANGE: 20060207 FORMER COMPANY: FORMER CONFORMED NAME: SCUDDER INTERNATIONAL FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SCUDDER INTERNATIONAL INVESTMENTS LTD DATE OF NAME CHANGE: 19761203 0000088053 S000006030 Deutsche CROCI International Fund C000016568 Class A SUIAX C000016571 Class C SUICX C000016572 Class S SCINX C000016573 Institutional Class SUIIX C000149477 Class R6 SUIRX N-Q 1 nq053117int_cint.htm DEUTSCHE CROCI INTERNATIONAL FUND

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

_______________________________

Investment Company Act file number: 811-00642

Deutsche International Fund, Inc.

(Exact name of registrant as specified in charter)

 

345 Park Avenue
New York, NY 10154-0004

(Address of principal executive offices) (Zip code)

 

Paul Schubert

345 Park Avenue

New York, NY 10154-0004

(Name and address of agent for service)

Registrant's telephone number, including area code: (212) 250-3220

Date of fiscal year end: 8/31

Date of reporting period: 5/31/2017

 

ITEM 1. SCHEDULE OF INVESTMENTS

 

 

Investment Portfolio                                                         as of May 31, 2017 (Unaudited)

 

 

Deutsche CROCI® International Fund

 

 

  Shares   Value ($)
Common Stocks 96.4%
Finland 2.1%
Fortum Oyj  (Cost $21,985,890)   1,484,998   23,654,673
France 10.0%
Cie Generale des Etablissements Michelin (a)   168,011   21,138,326
Danone SA     310,981   23,084,408
L'Oreal SA     106,875   22,865,039
Pernod Ricard SA     173,056   23,503,244
Sanofi     233,245   23,101,918
(Cost $108,205,754)   113,692,935
Germany 9.9%
Bayer AG (Registered)     177,458   23,542,920
Beiersdorf AG     217,265   23,332,566
Continental AG     97,831   21,759,882
Merck KGaA     183,391   22,136,007
Siemens AG (Registered)     149,673   21,361,561
(Cost $97,821,203)   112,132,936
Hong Kong 7.9%
CLP Holdings Ltd.     2,049,530   22,408,577
HK Electric Investments & HK Electric Investments Ltd. "SS", 144A, (Units)     24,706,000   22,700,523
Hong Kong & China Gas Co., Ltd.     10,882,502   23,266,130
MTR Corp., Ltd.     3,747,085   21,349,953
(Cost $77,192,677)   89,725,183
Japan 22.8%
ANA Holdings, Inc.     7,216,000   23,645,024
Astellas Pharma, Inc.     1,592,100   20,104,306
Bridgestone Corp.     518,540   21,781,021
Central Japan Railway Co.     126,700   20,746,767
Daiichi Sankyo Co., Ltd.     983,600   21,568,150
ITOCHU Corp.     1,538,400   21,850,142
Osaka Gas Co., Ltd.     5,802,000   22,909,387
Secom Co., Ltd.     300,100   21,943,204
Sekisui House Ltd.     1,312,100   22,510,068
Subaru Corp.     564,100   19,074,984
Sumitomo Electric Industries Ltd.     1,331,300   21,102,457
Toyota Industries Corp.     434,918   21,873,528
(Cost $263,274,747)   259,109,038
Netherlands 2.0%
Koninklijke DSM NV  (Cost $19,431,874)   303,112   22,561,575
Singapore 3.8%
Keppel Corp., Ltd.     4,600,105   21,377,281
Singapore Airlines Ltd.     2,925,682   21,165,813
(Cost $60,085,531)   42,543,094
Spain 2.1%
Iberdrola SA  (Cost $21,605,888)   3,018,233   24,065,983
Switzerland 16.1%
ABB Ltd. (Registered)     888,528   22,319,846
Givaudan SA (Registered)     11,094   22,759,566
Kuehne + Nagel International AG (Registered)     143,792   23,204,470
Nestle SA (Registered)     278,463   23,762,291
Novartis AG (Registered)     281,193   23,022,668
Roche Holding AG (Genusschein)     82,863   22,740,164
Schindler Holding AG     105,758   22,679,197
Wolseley PLC     341,864   22,508,266
(Cost $167,725,279)   182,996,468
United Kingdom 19.7%
British American Tobacco PLC     320,440   22,831,772
Bunzl PLC     703,014   22,029,027
Diageo PLC     748,359   22,437,483
GlaxoSmithKline PLC     1,089,227   23,907,177
Imperial Brands PLC     438,845   20,519,458
Johnson Matthey PLC     569,118   22,819,687
Kingfisher PLC     5,084,049   21,295,825
National Grid PLC     1,529,880   21,475,949
Persimmon PLC     722,022   22,838,611
Smith & Nephew PLC     1,321,373   23,052,173
(Cost $216,304,125)   223,207,162
Total Common Stocks (Cost $1,053,632,968)   1,093,689,047
Preferred Stock 2.0%
Germany  
Henkel AG & Co. KGaA  (Cost $19,394,135)   158,439   22,238,895
Securities Lending Collateral 2.0%
Deutsche Government & Agency Securities Portfolio "Deutsche Government Cash Institutional Shares", 0.74% (b) (c) (Cost $22,762,243)     22,762,243   22,762,243
Cash Equivalents 1.1%
Deutsche Central Cash Management Government Fund, 0.85% (b) (Cost $11,974,146)     11,974,146   11,974,146
  % of
Net Assets
  Value ($)
Total Investment Portfolio (Cost $1,107,763,492) † 101.5   1,150,664,331
Other Assets and Liabilities, Net (1.5)   (16,471,170)
Net Assets 100.0   1,134,193,161
                     

 

For information on the Fund's policies regarding the valuation of investments and other significant accounting policies, please refer to the Fund's most recent semi-annual or annual financial statements.
The cost for federal income tax purposes was $1,111,055,991.  At May 31, 2017, net unrealized appreciation for all securities based on tax cost was $39,608,340.  This consisted of aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost of $81,502,808 and aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value of $41,894,468.
(a) All or a portion of these securities were on loan. In addition, "Other Assets and Liabilities, Net" may include pending sales that are also on loan. The value of securities loaned at May 31, 2017 amounted to $21,138,200, which is 1.9% of net assets.
(b) Affiliated fund managed by Deutsche Investment Management Americas Inc.  The rate shown is the annualized seven-day yield at period end.
(c) Represents collateral held in connection with securities lending.  Income earned by the Fund is net of borrower rebates.
144A: Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.

 

At May 31, 2017, the Fund had the following open forward foreign currency exchange contracts:

 

Contracts to Deliver  In Exchange For  Settlement
Date
  Unrealized
Depreciation ($)
  Counterparty
JPY   29,187,007,164   USD   262,645,979   6/30/2017   (1,264,136)  Citigroup, Inc.

 

Currency Abbreviations
JPY Japanese Yen    
USD United States Dollar    

 

 
At May 31, 2017 the Deutsche CROCI International Fund had the following sector diversification:
Sector Diversification Market Value ($)   As a % of Common Stocks & Preferred Stock  
Industrials   286,180,551             26 %  
Consumer Staples   204,575,156             18 %  
Health Care   203,175,483             18 %  
Consumer Discretionary   193,374,702             17 %  
Utilities   160,481,222             15 %  
Materials   68,140,828               6 %  
Total 1,115,927,942           100 %  
                 

Sector diversification is subject to change.

 

Fair Value Measurements

 

Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments).The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.

 

The following is a summary of the inputs used as of May 31, 2017 in valuing the Fund's investments.

 

 

Assets   Level 1   Level 2   Level 3   Total
Common Stocks                
  Finland $ 23,654,673 $ $ $ 23,654,673
  France   113,692,935       113,692,935
  Germany   112,132,936       112,132,936
  Hong Kong   89,725,183       89,725,183
  Japan   259,109,038       259,109,038
  Netherlands   22,561,575       22,561,575
  Singapore   42,543,094       42,543,094
  Spain   24,065,983       24,065,983
  Switzerland   182,996,468       182,996,468
  United Kingdom   223,207,162       223,207,162
Preferred Stock   22,238,895       22,238,895
Short-Term Investments (d)   34,736,389       34,736,389
Total $ 1,150,664,331 $ $ $ 1,150,664,331
Liabilities   Level 1   Level 2   Level 3   Total
Derivatives (e)                
  Forward Foreign Currency Exchange Contracts $ $ (1,264,136) $ $ (1,264,136)
Total $ $ (1,264,136) $ $ (1,264,136)

 

There have been no transfers between fair value measurement levels during the period ended May 31, 2017.
(d) See Investment Portfolio for additional detailed catergorizations.
(e) Derivatives include unrealized appreciation (depreciation) on open forward foreign currency exchange contracts.

 

Derivatives

 

The following table presents, by major type of derivative contract, the unrealized appreciation (depreciation) of the Fund's derivative instruments as of May 31, 2017 categorized by the primary underlying risk exposure.

 

 

 

Primary Underlying Risk Disclosure

Forward Currency Contracts
Foreign Exchange Contracts   $  (1,264,136)

  

ITEM 2. CONTROLS AND PROCEDURES
   
  (a) The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
   
  (b) There have been no changes in the registrant’s internal control over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting.
   
ITEM 3. EXHIBITS
   
  Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant: Deutsche CROCI® International Fund, a series of Deutsche International Fund, Inc.
   
By:

/s/Brian E. Binder

Brian E. Binder

President

   
Date: July 21, 2017

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:

/s/Brian E. Binder

Brian E. Binder

President

   
Date: July 21, 2017
   
   
   
By:

/s/Paul Schubert

Paul Schubert

Chief Financial Officer and Treasurer

   
Date: July 21, 2017

EX-99.CERT 2 ex99cert.htm CERTIFICATIONS

CERTIFICATIONS

I, Brian E. Binder, certify that:

1.I have reviewed this report on Form N-Q of Deutsche CROCI® International Fund, a series of Deutsche International Fund, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

   
By:

/s/Brian E. Binder

Brian E. Binder

President

   
Date: July 21, 2017

 

 
 

CERTIFICATIONS

I, Paul Schubert, certify that:

1.I have reviewed this report on Form N-Q of Deutsche CROCI® International Fund, a series of Deutsche International Fund, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

   
By:

/s/Paul Schubert

Paul Schubert

Chief Financial Officer and Treasurer

   
Date: July 21, 2017